Table 1.
Biomarker | Sample type | Study design |
Diabetes type |
Population | Morphometric associations |
Reference |
---|---|---|---|---|---|---|
| ||||||
Advanced Glycation End Products | Plasma/Urine | Prospective | Type 1 | NHDNS |
|
Beisswenger et al,200546 |
Beisswenger et al,201348 | ||||||
Beisswenger et al,201449 | ||||||
| ||||||
Serum | Cross-sectional | Type 2 | American Indians |
|
Beisswenger et al,200546 | |
Saulnier et al, 201647 | ||||||
| ||||||
Beta-2 Microglobulin | Urine | Cross-sectional | Type 2 | Japanese |
|
Mise et al, 201674 |
| ||||||
Bradykinin | Plasma | Cross-sectional | Type 1 | RASS |
|
Wheelock et al, 201762 |
| ||||||
Plasma | Prospective | Type 1 | RASS |
|
Wheelock et al 201762 | |
| ||||||
Monocyte Chemo-attractant Protein 1 | Urine | Cross-sectional | Type 1 | RASS |
|
Fufaa et al, 201643 |
| ||||||
Urine | Prospective | Type 1 | RASS |
|
Fufaa et al, 201643 | |
| ||||||
N-Acetyl-β-d-Glucosaminidase | Urine | Cross-sectional | Type 2 | Japanese |
|
Mise et al, 201674 |
| ||||||
Tumor Necrosis Factor Receptor 1 | Serum | Cross-sectional | Type 2 | American Indians |
|
Pavkov et al, 201642 |
| ||||||
Tumor Necrosis Factor Receptor 2 | Serum | Cross-sectional | Type 2 | American Indians |
|
Pavkov et al, 201642 |
| ||||||
White blood cell fractions | Blood | Cross-sectional | Type 2 | American Indians |
|
Wheelock et al 201766 |
Morphometric measures are shown in bold where there is a statistically significant association with the biomarker. Positive associations are indicated by an up arrow and negative associations by a down arrow – both arrows are shown when variation in findings is observed for different sub-types of biomarker.
Association seen only in women.
Abbreviations used: NHDNS – natural history diabetic nephropathy study; RASS – renin angiotensin system study; %GS – percentage of global glomerular sclerosis; VG – mean glomerular volume; Vv(Int/cortex) – cortical interstitial fractional volume; Vv(Mes/glom) – mesangial fractional volume per glomerulus; (Sv(PGBM/glom) – surface density of the peripheral glomerular basement membrane per glomerulus; TFS/glom – total filtration surface per glomerulus; GBM width – glomerular basement membrane width; FPW – foot process width; % ECF – percentage of endothelial cell fenestrations; IFTA – interstitial fibrosis and tubular atrophy.